A common signaling cascade may underlie “addiction” to the Src, BCR-ABL, and EGF receptor oncogenes
- 1 November 2006
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 10 (5), 425-435
- https://doi.org/10.1016/j.ccr.2006.09.014
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Epidermal Growth Factor–Independent Transformation of Ba/F3 Cells with Cancer-Derived Epidermal Growth Factor Receptor Mutants Induces Gefitinib-Sensitive Cell Cycle ProgressionCancer Research, 2005
- Differential Effects of Gefitinib and Cetuximab on Non–small-cell Lung Cancers Bearing Epidermal Growth Factor Receptor MutationsJNCI Journal of the National Cancer Institute, 2005
- Establishment of a human non‐small cell lung cancer cell line resistant to gefitinibInternational Journal of Cancer, 2005
- Chlorogenic acid inhibits Bcr-Abl tyrosine kinase and triggers p38 mitogen-activated protein kinase–dependent apoptosis in chronic myelogenous leukemic cellsBlood, 2004
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProceedings of the National Academy of Sciences, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- The Pro-apoptotic Ras Effector Nore1 May Serve as a Ras-regulated Tumor Suppressor in the LungJournal of Biological Chemistry, 2003
- Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markersCell Death & Differentiation, 1998
- Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling PathwaysScience, 1997